The Cooper Companies: Strategic M&A & Innovation Indicating Firm Future Prospects In Surgical Healthcare Markets!

The Cooper Companies, Inc., a global medical device company, started its fiscal year 2025 with a notable performance, achieving record Q1 revenues and earnings. The company reported consolidated revenues of $965 million, which were up 4% year-over-year, and organic growth of 5%. The financial performance was bolstered by a robust showing from both its business segments: CooperVision, which had a revenue increase of 4% (6% organically), and CooperSurgical, seeing a 3% uptick (2% organically). Non-GAAP earnings per share were reported at $0.92, a 7.4% increase.